BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30621041)

  • 1. Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.
    De Paepe B
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30621041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis.
    Catalán-García M; Garrabou G; Morén C; Guitart-Mampel M; Hernando A; Díaz-Ramos À; González-Casacuberta I; Juárez DL; Bañó M; Enrich-Bengoa J; Emperador S; Milisenda JC; Moreno P; Tobías E; Zorzano A; Montoya J; Cardellach F; Grau JM
    Clin Sci (Lond); 2016 Oct; 130(19):1741-51. PubMed ID: 27413019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA depletion in sporadic inclusion body myositis.
    Bhatt PS; Tzoulis C; Balafkan N; Miletic H; Tran GTT; Sanaker PS; Bindoff LA
    Neuromuscul Disord; 2019 Mar; 29(3):242-246. PubMed ID: 30850168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis.
    Horvath R; Fu K; Johns T; Genge A; Karpati G; Shoubridge EA
    J Neuropathol Exp Neurol; 1998 May; 57(5):396-403. PubMed ID: 9596410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
    Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
    J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial abnormalities in inclusion-body myositis.
    Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
    Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5.
    Oikawa Y; Izumi R; Koide M; Hagiwara Y; Kanzaki M; Suzuki N; Kikuchi K; Matsuhashi T; Akiyama Y; Ichijo M; Watanabe S; Toyohara T; Suzuki T; Mishima E; Akiyama Y; Ogata Y; Suzuki C; Hayashi H; Kodama EN; Hayashi KI; Itoi E; Aoki M; Kure S; Abe T
    PLoS One; 2020; 15(12):e0231064. PubMed ID: 33264289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
    Hedberg-Oldfors C; Lindgren U; Basu S; Visuttijai K; Lindberg C; Falkenberg M; Larsson Lekholm E; Oldfors A
    Brain Pathol; 2021 May; 31(3):e12931. PubMed ID: 33354847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
    Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
    Askanas V; Engel WK; Nogalska A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis.
    Schröder JM; Molnar M
    Mol Cell Biochem; 1997 Sep; 174(1-2):277-81. PubMed ID: 9309700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis.
    Amici DR; Pinal-Fernandez I; Mázala DA; Lloyd TE; Corse AM; Christopher-Stine L; Mammen AL; Chin ER
    Acta Neuropathol Commun; 2017 Mar; 5(1):24. PubMed ID: 28330496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance Exercise Improves Mitochondrial Quality Control in a Rat Model of Sporadic Inclusion Body Myositis.
    Koo JH; Kang EB; Cho JY
    Gerontology; 2019; 65(3):240-252. PubMed ID: 30641518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
    Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
    Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients.
    Santorelli FM; Sciacco M; Tanji K; Shanske S; Vu TH; Golzi V; Griggs RC; Mendell JR; Hays AP; Bertorini TE; Pestronk A; Bonilla E; DiMauro S
    Ann Neurol; 1996 Jun; 39(6):789-95. PubMed ID: 8651651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial pathology in inclusion body myositis.
    Lindgren U; Roos S; Hedberg Oldfors C; Moslemi AR; Lindberg C; Oldfors A
    Neuromuscul Disord; 2015 Apr; 25(4):281-8. PubMed ID: 25638290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular phosphates in inclusion body myositis--a 31P magnetic resonance spectroscopy study.
    Argov Z; Taivassalo T; De Stefano N; Genge A; Karpati G; Arnold DL
    Muscle Nerve; 1998 Nov; 21(11):1523-5. PubMed ID: 9771678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
    Lodi R; Taylor DJ; Tabrizi SJ; Hilton-Jones D; Squier MV; Seller A; Styles P; Schapira AH
    Brain; 1998 Nov; 121 ( Pt 11)():2119-26. PubMed ID: 9827771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers.
    Buzkova J; Nikkanen J; Ahola S; Hakonen AH; Sevastianova K; Hovinen T; Yki-Järvinen H; Pietiläinen KH; Lönnqvist T; Velagapudi V; Carroll CJ; Suomalainen A
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30373890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.